CCP
MRK icon

Corient Capital Partners’s Merck MRK Stock Holding History

Corient Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$12.8M Hold
140,938
– – 0.96% 15
2022
Q2 		$12.8M Buy
140,938
+5,247
+4% +$465K 0.97% 16
2022
Q1 		$11.1M Buy
135,691
+6,186
+5% +$488K 0.74% 23
2021
Q4 		$9.93M Buy
129,505
+4,550
+4% +$362K 0.66% 29
2021
Q3 		$9.38M Buy
124,955
+11,767
+10% +$895K 0.69% 27
2021
Q2 		$8.8M Buy
113,188
+15,312
+16% +$1.14M 0.64% 29
2021
Q1 		$7.2M Buy
97,876
+2,445
+3% +$180K 0.62% 34
2020
Q4 		$7.45M Buy
95,431
+2,250
+2% +$172K 0.74% 28
2020
Q3 		$7.38M Buy
93,181
+5,233
+6% +$410K 0.85% 20
2020
Q2 		$6.49M Buy
87,948
+13,203
+18% +$994K 0.79% 27
2020
Q1 		$5.49M Buy
74,745
+18,275
+32% +$1.44M 0.87% 25
2019
Q4 		$4.9M Buy
56,470
+681
+1% +$55.9K 0.62% 33
2019
Q3 		$4.48M Buy
55,789
+10,350
+23% +$829K 0.63% 35
2019
Q2 		$3.63M Buy
45,439
+2,315
+5% +$177K 0.56% 39
2019
Q1 		$3.42M Buy
43,124
+14,022
+48% +$1.05M 0.56% 36
2018
Q4 		$2.12M Buy
29,102
+5,955
+26% +$420K 0.38% 67
2018
Q3 		$1.57M Hold
23,147
– – 0.26% 114
2018
Q2 		$1.34M Buy
23,147
+3,383
+17% +$191K 0.23% 125
2018
Q1 		$1.03M Sell
19,764
-3,592
-15% -$194K 0.19% 124
2017
Q4 		$1.25M Sell
23,356
-1,519
-6% -$84.2K 0.21% 115
2017
Q3 		$1.52M Sell
24,875
-2,867
-10% -$174K 0.29% 90
2017
Q2 		$1.7M Buy
27,742
+369
+1% +$22.5K 0.26% 102
2017
Q1 		$1.66M Buy
27,373
+218
+0.8% +$13.2K 0.26% 100
2016
Q4 		$1.52M Sell
27,155
-544
-2% -$31.8K 0.27% 100
2016
Q3 		$1.65M Buy
+27,699
New +$1.62M 0.31% 91

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Corient Capital Partners's MRK Position: Q3 2022 in Review

Corient Capital Partners held its Merck (MRK) position steady in Q3 2022 at 140,938 shares worth $12.8M. The position accounts for 0.96% of the portfolio, ranked #15.

Corient Capital Partners first reported a position in MRK in Q3 2016 and has held it in 25 quarters since. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Corient Capital Partners held 140,938 shares of Merck worth $12.8M as of Q3 2022.
  • Corient Capital Partners left its Merck share count unchanged in Q3 2022.
  • Merck made up 0.96% of Corient Capital Partners's portfolio in Q3 2022, its #15 holding.
  • Corient Capital Partners first reported a position in Merck in Q3 2016 and has held it in 25 quarters since.
  • 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.